Brussels - Delayed Quote EUR

UCB SA (UCB.BR)

120.00 +0.10 (+0.08%)
At close: April 18 at 5:35 PM GMT+2
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
5,252,000.00
5,252,000.00
5,517,000.00
5,777,000.00
5,347,000.00
Cost of Revenue
1,707,000.00
1,707,000.00
1,675,000.00
1,438,000.00
1,363,000.00
Gross Profit
3,545,000.00
3,545,000.00
3,842,000.00
4,339,000.00
3,984,000.00
Operating Expense
2,923,000.00
2,923,000.00
3,192,000.00
3,017,000.00
2,944,000.00
Operating Income
622,000.00
622,000.00
650,000.00
1,322,000.00
1,040,000.00
Net Non Operating Interest Income Expense
-129,000.00
-129,000.00
-64,000.00
-41,000.00
-55,000.00
Pretax Income
441,000.00
441,000.00
511,000.00
1,226,000.00
880,000.00
Tax Provision
98,000.00
98,000.00
91,000.00
170,000.00
119,000.00
Net Income Common Stockholders
343,000.00
343,000.00
418,000.00
1,058,000.00
732,000.00
Diluted NI Available to Com Stockholders
343,000.00
343,000.00
418,000.00
1,058,000.00
732,000.00
Basic EPS
1.74
1.81
2.20
5.60
3.87
Diluted EPS
1.69
1.76
2.14
5.45
3.77
Basic Average Shares
189,346.17
189,690.00
189,619.00
188,973.00
189,035.00
Diluted Average Shares
194,725.54
195,190.00
194,834.00
194,177.00
194,245.00
Total Operating Income as Reported
604,000.00
604,000.00
585,000.00
1,284,000.00
971,000.00
Total Expenses
4,630,000.00
4,630,000.00
4,867,000.00
4,455,000.00
4,307,000.00
Net Income from Continuing & Discontinued Operation
343,000.00
343,000.00
418,000.00
1,058,000.00
732,000.00
Normalized Income
341,444.44
341,444.44
503,835.62
1,019,740.00
819,000.00
Interest Income
27,000.00
27,000.00
12,000.00
7,000.00
14,000.00
Interest Expense
144,000.00
144,000.00
71,000.00
45,000.00
68,000.00
Net Interest Income
-129,000.00
-129,000.00
-64,000.00
-41,000.00
-55,000.00
EBIT
585,000.00
585,000.00
582,000.00
1,271,000.00
948,000.00
EBITDA
1,276,000.00
1,276,000.00
1,171,000.00
1,594,000.00
1,302,000.00
Reconciled Cost of Revenue
1,707,000.00
1,707,000.00
1,675,000.00
1,438,000.00
1,363,000.00
Reconciled Depreciation
691,000.00
691,000.00
589,000.00
323,000.00
354,000.00
Net Income from Continuing Operation Net Minority Interest
343,000.00
343,000.00
420,000.00
1,055,000.00
732,000.00
Total Unusual Items Excluding Goodwill
2,000.00
2,000.00
-102,000.00
41,000.00
-100,000.00
Total Unusual Items
2,000.00
2,000.00
-102,000.00
41,000.00
-100,000.00
Normalized EBITDA
1,274,000.00
1,274,000.00
1,273,000.00
1,553,000.00
1,402,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
444.44
444.44
-18,164.38
5,740.00
-13,000.00
12/31/2020 - 1/4/2000
Yahoo Finance Plus Essential access required. Unlock Access

Related Tickers

TUB.BR Financière de Tubize SA
91.80
-0.65%
 
ARGX.BR argenx SE
342.00
+0.59%
 
ARGX argenx SE
358.41
-2.13%
 
ONWD.BR Onward Medical N.V.
5.32
+0.38%
 
GLPG.AS Galapagos NV
27.38
0.00%
 
DNTH Dianthus Therapeutics, Inc.
23.63
+1.24%
 
ASND Ascendis Pharma A/S
140.89
-0.90%
 
SWTX SpringWorks Therapeutics, Inc.
42.47
-3.72%
 
TRML Tourmaline Bio, Inc.
15.66
-6.12%
 
AGIO Agios Pharmaceuticals, Inc.
29.43
+1.38%